The purpose of writing this review on microballoons is to accumulate the recent literature with a special focus on the novel technological advancements in floating drug delivery system to achieve gastric retention. Microballoons (Hollow microsphere) promises to be a potential approach for gastric retention. Microballoons drug-delivery systems are based on noneffervescent system containing empty particles of spherical shape without core ideally having a size less than 200 micrometer. Microballoons drug delivery systems have shown to be of better significance in controlling release rate for drugs having site specific absorption. The floating microballoons showed gastroretentive controlled release delivery with efficient means of enhancing the bioavailability and promises to be a potential approach for gastric retention.
Introduction
Conventional oral dosage forms such as tablets, capsules provide a specific drug concentration in systemic circulation which do not release at the constant rate for prolonged period of time. Controlled release drug delivery system (CRDDS) provides drug release at a precontrolled, predictable rate either systematically or locally for intended duration of time and optimizes the therapeutic effect of a drug by controlling its release into the body with lower and less frequent dosing 1 .
Controlled-release drug delivery system is capable of achieving the benefits like maintenance of therapeutic amount of drug concentration in blood with controlled release rate for an extended time period; enhancement of activity of duration for short half-life drugs; elimination of side effects; reducing the fluctuations of drug concentration and frequency of dosing; it optimized therapy and better patient compliances 2, 3 .
Floating drug delivery system
Floating drug delivery system was described by Davis (1968) 1 
.
These are low-density based systems with sufficient buoyancy to float over the gastric contents. While the system is floating on the gastric contents, the drug is released slowly at the constant rate from the system. After release of drug, the residual system is evacuated from the stomach. This result in an increased GRT, reduce fluctuation of drug and thus enhances bioavailability. Many floating systems have been generated based on granules, powders, capsules, tablets, laminated films, beads and hollow microspheres 4, 5 .
It can be classified into two systems: 6,7
Effervescent System
Volatile liquid containing systems (Intragastric floating GRDDS) Gas-generating Systems (Intra gastric single layer and bilayered floating tablets, Multiple unit type floating pills)
Non-Effervescent Systems
Hydro colloidal gel barrier systems Hollow microspheres / microballoons loaded with drug in their outer polymer shell are prepared by a novel methods such as solvent evaporation or solvent diffusion/evaporation to create a hollow inner core. The drug and an enteric acrylic polymer mixture is dissolved in ethanol/dichloromethane solution and it is poured into an agitated solution of Poly Vinyl Alcohol (PVA) that as thermally controlled at 40 ºC. After the formation of stable emulsion, the organic solvent is evaporated from the emulsion by increasing the temperature under pressure or by continuous stirring 10 . The gas phase is generated in the droplet of dispersed polymer by the evaporation of dichloromethane and thus formed the hollow internal cavity in the microsphere of the polymer with drug. The microballoon is continuously float over the surface of an acidic dissolution media containing surfactant for more than 12 hours 11, 12 .
Mechanisms of Microballoons
Microballoons are low-density systems that have sufficient buoyancy to float over gastric fluid and remain in stomach for prolonged period of time. As the system floats over gastric fluid, the drug is released slowly at desired rate resulting in increased gastric retention with reduced fluctuations in plasma drug concentration. When microballoons come in contact with gastric fluid, the gel forms and polymers hydrate to form a colloidal gel barrier that controls the rate of fluid penetration into the device and consequent drug release. As the outer surface of the dosage form dissolves, the gel layer is maintained by the hydration of the adjacent hydrocolloid layer. The air trapped by the swollen polymer makes the density lower than the gastric fluid and confers buoyancy to the microspheres. However, a minimal gastric content needed to allow proper achievement of buoyancy 13, 14 . 
Materials for preparation of Microballoons

Drugs
Drugs with narrow therapeutic window in GI tract, mainly absorbed from stomach and upper part of GIT, locally act in the stomach, degrade in the colon, disturb normal colonic bacteria. 
Polymers
Cellulose acetate, chitosan, eudragit, acrycoat, methocil, polyacrylates, polyvinyl acetate, carbopol, agar, polyethylene oxide, polycarbonates, acrylic resins and polyethylene 11, 15, 16 . 
Processing Medium
It is used to harden the drug polymer emulsified droplets when the drug polymer solution is poured into it, should not interact with the former; mainly used processing medium are liquid paraffin, polyvinyl alcohol and water.
Surfactant
They are stabilizers or emulsifiers, play the role of hardening the microspheres as well. E.g. tween 80, span 80 and SLS.
Cross linking agent
Chemical cross-linking of microspheres can be achieved using cross linking agents such as formaldehyde, glutaraldehyde or by using di acid chlorides such as terephthaloyl chloride. The method is limited to drugs that do not have any chemical interaction with the cross-linking agent 18 .
Hardening agent
This helps to harden the microspheres formed in the processing medium eg n-hexane, petroleum ether (in case the processing medium is liquid paraffin) 19 .
Method of preparation
Solvent evaporation method
The polymers for the development of such systems include 
Fig 1: Solvent evaporation method
Emulsion solvent diffusion method
The mixture of drug polymer is dissolved in the solution of ethanol: dicloromethane and this mixture is adding dropwise to polyvinyl alcohol solution. This solution is stirred at 1500 rpm for 1 hour and at different temperature ranges 21 .
In the emulsion solvent diffusion method the affinity between the drug and organic solvent is stronger than that of organic solvent and aqueous solvent. The drug is dissolved in the organic solvent and the solution is dispersed in the aqueous solvent producing the emulsion droplets even though the organic solvent is miscible. The organic solvent diffuse gradually out of the emulsion droplets in to the surrounding aqueous phase and the aqueous phase diffuse into the droplets by which drug crystallizes 19, 20 (Fig 2) .
Solvent diffusion-evaporation technique
This technique is with slight modification of both emulsion The best formulation is selected on the basis of optimized result of various process variables such as polymer ratio, drug:
polymer ratio, stirring speed and concentration of emulsifier 22 .
Spray drying
Spray drying is the most widely employed industrial process for particle formation and drying. It is an ideal process where the required particle size distribution, bulk density and particle shape can be obtained in a single step 23 .
Fig 2: Emulsion solvent diffusion method
First of all, polymer is dissolved in a suitable volatile organic solvent such as dichloromethane, acetone etc. to form a slurry.
The slurry is then sprayed into the drying chamber, 
Stirring rate
It is obvious that the stirring rate affects size of microsphere.
The size of the resulting microspheres decreases with increasing agitation, but the increase is not statistically significant. It may be inferred that the agitation speed over the study range is not able to break up the bulk of the polymer into finer droplets 25, 26 .
Temperature of preparation
The study of optimum preparation temperature with respect to having higher porosity with a surface so rough as to crumble upon touching. As the preparation temperature increases, particle size decreases. This is because at high temperature, emulsion is less viscous and it becomes much easier for the emulsion to be broken down into smaller droplets at the same power of mixing input 27 . Microballoons prepared at high temperature are found to be a uniform internal pore distribution.
Microspheres formed at higher temperature gives very slow release rates after their initial drug release.
Plasticizers
Due to the addition of plasticizer, it gives elasticity and flexibility to the wall of material so that it never gets brittle or ruptured under pressure. It is also observed that the release of the drug increased significantly with the increase of plasticizer concentration 28 .
Volume of aqueous phase (Continuous phase)
The effect of various volumes on the formation of hollow microspheres. When the volume of aqueous phase increases the particle size decreases and thus buoyancy increases. Using of large volumes of the external aqueous phase reduces the required stirring times. The solubility of dichloromethane in water is 1% w/v. Using a larger volume (400 to 500 ml), the diffusion of dichloromethane into the aqueous phase, and hence the solidification of particles, occurred faster, when compared to a volume of 200 ml 29 .
Solvent ratio
The bridging liquid plays a key role in microsphere preparation.
Very small volume of the bridging liquid gives irregularly shaped microspheres while very large volume of bridging liquid prevents from solidifying of the emulsion droplets. Therefore, the amount of dichloromethane needs to be carefully controlled 30 . The ratio of dichloromethane with ethanol affects the morphology of the microspheres so optimized the ratio which can give best spherical shape. The ratio of ethanol to dichloromethane is 2:1 29 obtains the best result with spherical shape.
Faster rate of solvent evaporation gives smooth surface, spherical shape and lower encapsulation.
Amount of polymer and viscosity
Smaller microballoons are formed at a lower polymer concentration and has a larger surface area exposed to dissolution medium giving faster release of drug 31 . 
Effect of solvent
Emulsifier concentration
The effect of emulsifier concentration on particle size is studied by the scientist. They found that the particle size and size distribution is increased when the surfactant concentration is reduced from 1% to 0.25% (w/w). The role of the emulsifier (surfactant) is to decrease the interfacial tension between the dispersed droplets and the continuous phase, as well as to protect the droplets from collision and coalescence 33 . At lower emulsifier concentrations, droplets are more likely to collide and fused to form larger globules; it is insufficient to shield the entire droplet surface. At higher concentration of emulsifier, it reduces the encapsulation efficiency 25 . Hence, the optimum concentration of the emulsifier should be identified 33 .
Evaluation of hollow microspheres
Percentage Yield
The percentage yield of the hollow microspheres is determined for drug and is calculated using the following equation 34, 35, 36 .
Yield=M/Mo x 100
Where M = weight of beads Mo = total expected weight of drug and polymer. 37, 38 Microballoons are evaluated by their micromeritic properties such as particle shape and size, bulk density, tapped density, Hausner's ratio and flow properties which is determined by carr's index and angle of repose 37 . Particle size is determined by an optical microscopy, and average diameter of particle is calculated with the help of calibrated ocular micrometer (by measuring 200 to 300 particles) 38 . True density is determined by liquid displacement method; tapped density and compressibility index are calculated by measuring the change in volume using a bulk density apparatus; angle of repose is The compressibility/carr's index was calculated using following formula:
Micromeritic properties
I = V b -V t / V b x 100
Where, V b is the bulk volume and V t is the tapped volume. The value given below 15% indicates a powder with usually give rise to good flow characteristics, whereas above 25% indicate poor flow ability. True density is determined using a Helium densitometer. Porosity (e) is calculated using the following equation: e = {1-(tapped density/true density)} ×100
Angle of repose of the micro balloons are determined by the fixed funnel method.
In vitro buoyancy
Appropriate quantity of hollow/empty microspheres are placed 
In-vitro drug release studies
The release rate of hollow microspheres are determined in a 13 Patented Microballoons (Hollow Microspheres) ( Table 2) 14 Conclusions
In recent review, we concluded that the floating hollow microspheres showed gastro retentive controlled release delivery system, promises to be a potential approach for gastric retention.
Microballoons are low-density, sufficient buoyancy to float over gastric contents and remain in stomach for prolonged period.
The drug is released slowly at desired rate when it floats over gastric contents resulting reduced fluctuations in plasma drug concentration.
It is efficient means of enhancing the bioavailability. Optimized microballoons will find the central place in novel drug delivery, particularly in diseased cell sorting, diagnostics, gene & genetic materials, safe, targeted and effective in vivo delivery. 
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